Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination

Since the first cases were discovered at the end of 2019, the ongoing coronavirus disease 2019 (COVID-19) pandemic has significantly changed the lives of people around the world. Vaccines to prevent infection from its causative organism, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), were developed by the end of 2020 and have now become humanity's hope of regaining normalcy by acquiring protective immunity against COVID-19. However, as vaccines against COVID-19 have been distributed globally at an unprecedented rate, cases of serious adverse events post-vaccination have been accumulating.

Source: International Journal of Infectious Diseases - December 24, 2021 Category: Infectious Diseases Authors: Jimin Hwang, Young Joo Han, Dong Keon Yon, Seung Won Lee, Beom Kyung Kim, Se Bee Lee, Min Ho Lee, Seung Hyun Park, Ai Koyanagi, Louis Jacob, Kalthoum Tizaoui, Seung Up Kim, Jae Il Shin, Lee Smith Source Type: research